Holocene Advisors, LP Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Holocene Advisors, LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$83.14 - $145.99 $56.5 Million - $99.2 Million	-679,238 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$110.08 - $142.92 $42.4 Million - $55.1 Million	385,395 Added 131.16%	679,238 $80.5 Million
Q4 2021 Feb 14, 2022	SELL	$99.73 - $148.48 $515,703 - $767,790	-5,171 Reduced 1.73%	293,843 $40.5 Million
Q3 2021 Nov 15, 2021	BUY	$98.85 - $138.91 $28.3 Million - $39.8 Million	286,750 Added 2338.14%	299,014 $41.5 Million
Q2 2021 Aug 16, 2021	BUY	$65.78 - $105.02 $806,725 - $1.29 Million	12,264 New	12,264 $1.19 Million
Q1 2021 May 17, 2021	SELL	$64.07 - $91.75 $794,019 - $1.14 Million	-12,393 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$65.07 - $98.24 $806,412 - $1.22 Million	12,393 New	12,393 $1.06 Million
Q3 2020 Nov 16, 2020	SELL	$59.04 - $77.95 $4.77 Million - $6.3 Million	-80,865 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$29.01 - $74.23 $11.5 Million - $29.5 Million	-396,891 Reduced 83.07%	80,865 $5.91 Million
Q1 2020 May 15, 2020	BUY	$27.51 - $57.29 $13.1 Million - $27.4 Million	477,756 New	477,756 $16.3 Million

792K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $2.8B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Holocene Advisors, LP, based on Form 13F filings with the SEC.

Stay updated on Holocene Advisors, LP with notifications on news.